跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 19,436 条关于
“bone marrow fibrosis”
全部
19,436
临床试验
15,755
药物
536
机构
108
资讯
3,037
去年
First Patient Enrolled in Phase Ib/II Trial of Tasquinimod for Treatment-Resistant Myelofibrosis
去年
Phase 3 Trial Advances Imetelstat as Potential Game-Changer for JAK Inhibitor-Resistant Myelofibrosis
去年
FDA Grants Fast Track Designation to Sumitomo's Nuvisertib for Myelofibrosis Treatment
2个月前
Ipsen Acquires Kartos Therapeutics for $450M to Develop Navtemadlin, an MDM2 Inhibitor for Myelofibrosis
5年前
Interferon-Alpha Shows Promise in Reducing Myelofibrosis Risk and Mortality in Polycythemia Vera Patients
去年
Phase 1 Trial of Type II JAK2 Inhibitor AJ1-11095 Underway for Myelofibrosis
7个月前
Active Biotech's Tasquinimod Myelofibrosis Trial Resumes After FDA Approval of Protocol Amendment
去年
Ryvu Therapeutics Initiates Phase II Trial of RVU120 in Myelofibrosis
去年
Navtemadlin Shows Promise in JAK Inhibitor-Refractory Myelofibrosis
12年前
Ruxolitinib Demonstrates Sustained Efficacy in Myelofibrosis Treatment
第 1 页,共 304 页
上一页
下一页